Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage
Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain un...
Gespeichert in:
Veröffentlicht in: | Journal of cutaneous medicine and surgery 2022-11, Vol.26 (6), p.600-603 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 603 |
---|---|
container_issue | 6 |
container_start_page | 600 |
container_title | Journal of cutaneous medicine and surgery |
container_volume | 26 |
creator | Chang, Jasmine Litvinov, Ivan V. Ly, Christina Netchiporouk, Elena Tsoukas, Alexander Thuraisingam, Thusanth Starr, Michael Powell, Mathieu Christodoulou, George Shamout, Yassein |
description | Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain undiagnosed. Early detection and referral to a rheumatologist are crucial to optimize care and minimize irreversible erosive joint damage. To improve the rheumatology referral process, the authors propose a risk stratification tool to identify and triage patients with possible psoriatic arthritis. With the aim of ultimately assisting in early treatment initiation, this risk stratification algorithm can be used in both dermatology and primary care clinics. It is based on the Psoriasis Epidemiology Screening Tool (PEST) combined with the ClASsification criteria for Psoriatic Arthritis (CASPAR). This article intends to provide a rationale for further prospective studies whose objective would be to validate this screening algorithm. |
doi_str_mv | 10.1177/12034754221128796 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9729972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_12034754221128796</sage_id><sourcerecordid>2747221065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-22b444558429b4ce26d882b87ca596418197a0a067462e5e78258de67057b5a13</originalsourceid><addsrcrecordid>eNp1kktv1DAQxyMEoqXwAbggS1zKIcV2_Eg4VFqVFIqKWHW358jJTnanJPFie1fafrp-NLyklJc4WPZofvOfhydJXjJ6wpjWbxmnmdBScM4Yz3WhHiWHTDGZakaLx_Ed_ekeOEieeX9DKWVMiqfJQaY4E1mmD5O764Ad3pqAdiC2JWEFZOqtQ-PRk3KNC-jRdna5I7PGAQw4LMnc2o4cT8vZ_M07MiFX6L-SWXBRpMVmlPphQoxqrSOlcd2OXEELzplun2ZMEbAhExdWDkNMNo02DMGTYMlnHLDHWyAXzsEWnMe6A1I663EL5JPFIZD3pjdLeJ48aU3n4cX9fZRcn5fzs4_p5ZcPF2eTy7QRSoWU81oIIWUueFGLBrha5Dmvc90YWSjBclZoQw1VWigOEnTOZb4ApanUtTQsO0pOR931pu5h0cRKYy_V2mFv3K6yBqs_PQOuqqXdVoXmRTxR4PhewNlvG_Ch6tE30HVmALvxFY-MyDMm84i-_gu9sRs3xPYiJXT8bqpkpNhINXEs3kH7UAyj1X4_qn_2I8a8-r2Lh4ifCxGBkxHwcba_0v5f8TsSB8UG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2747221065</pqid></control><display><type>article</type><title>Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Chang, Jasmine ; Litvinov, Ivan V. ; Ly, Christina ; Netchiporouk, Elena ; Tsoukas, Alexander ; Thuraisingam, Thusanth ; Starr, Michael ; Powell, Mathieu ; Christodoulou, George ; Shamout, Yassein</creator><creatorcontrib>Chang, Jasmine ; Litvinov, Ivan V. ; Ly, Christina ; Netchiporouk, Elena ; Tsoukas, Alexander ; Thuraisingam, Thusanth ; Starr, Michael ; Powell, Mathieu ; Christodoulou, George ; Shamout, Yassein</creatorcontrib><description>Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain undiagnosed. Early detection and referral to a rheumatologist are crucial to optimize care and minimize irreversible erosive joint damage. To improve the rheumatology referral process, the authors propose a risk stratification tool to identify and triage patients with possible psoriatic arthritis. With the aim of ultimately assisting in early treatment initiation, this risk stratification algorithm can be used in both dermatology and primary care clinics. It is based on the Psoriasis Epidemiology Screening Tool (PEST) combined with the ClASsification criteria for Psoriatic Arthritis (CASPAR). This article intends to provide a rationale for further prospective studies whose objective would be to validate this screening algorithm.</description><identifier>ISSN: 1203-4754</identifier><identifier>EISSN: 1615-7109</identifier><identifier>DOI: 10.1177/12034754221128796</identifier><identifier>PMID: 36214337</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Arthritis, Psoriatic - diagnosis ; Arthritis, Psoriatic - drug therapy ; Arthritis, Psoriatic - epidemiology ; Humans ; Medical screening ; Original ; Prospective Studies ; Psoriasis ; Psoriasis - complications ; Psoriasis - drug therapy ; Psoriasis - epidemiology ; Psoriatic arthritis ; Referral and Consultation ; Rheumatology ; Risk Assessment</subject><ispartof>Journal of cutaneous medicine and surgery, 2022-11, Vol.26 (6), p.600-603</ispartof><rights>The Author(s) 2022</rights><rights>The Author(s) 2022 2022 Canadian Dermatology Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-22b444558429b4ce26d882b87ca596418197a0a067462e5e78258de67057b5a13</citedby><cites>FETCH-LOGICAL-c466t-22b444558429b4ce26d882b87ca596418197a0a067462e5e78258de67057b5a13</cites><orcidid>0000-0003-0562-4675 ; 0000-0001-8414-6354 ; 0000-0001-5063-8991 ; 0000-0002-6692-7787</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/12034754221128796$$EPDF$$P50$$Gsage$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/12034754221128796$$EHTML$$P50$$Gsage$$Hfree_for_read</linktohtml><link.rule.ids>230,314,777,781,882,21800,27905,27906,43602,43603</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36214337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, Jasmine</creatorcontrib><creatorcontrib>Litvinov, Ivan V.</creatorcontrib><creatorcontrib>Ly, Christina</creatorcontrib><creatorcontrib>Netchiporouk, Elena</creatorcontrib><creatorcontrib>Tsoukas, Alexander</creatorcontrib><creatorcontrib>Thuraisingam, Thusanth</creatorcontrib><creatorcontrib>Starr, Michael</creatorcontrib><creatorcontrib>Powell, Mathieu</creatorcontrib><creatorcontrib>Christodoulou, George</creatorcontrib><creatorcontrib>Shamout, Yassein</creatorcontrib><title>Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage</title><title>Journal of cutaneous medicine and surgery</title><addtitle>J Cutan Med Surg</addtitle><description>Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain undiagnosed. Early detection and referral to a rheumatologist are crucial to optimize care and minimize irreversible erosive joint damage. To improve the rheumatology referral process, the authors propose a risk stratification tool to identify and triage patients with possible psoriatic arthritis. With the aim of ultimately assisting in early treatment initiation, this risk stratification algorithm can be used in both dermatology and primary care clinics. It is based on the Psoriasis Epidemiology Screening Tool (PEST) combined with the ClASsification criteria for Psoriatic Arthritis (CASPAR). This article intends to provide a rationale for further prospective studies whose objective would be to validate this screening algorithm.</description><subject>Arthritis, Psoriatic - diagnosis</subject><subject>Arthritis, Psoriatic - drug therapy</subject><subject>Arthritis, Psoriatic - epidemiology</subject><subject>Humans</subject><subject>Medical screening</subject><subject>Original</subject><subject>Prospective Studies</subject><subject>Psoriasis</subject><subject>Psoriasis - complications</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriasis - epidemiology</subject><subject>Psoriatic arthritis</subject><subject>Referral and Consultation</subject><subject>Rheumatology</subject><subject>Risk Assessment</subject><issn>1203-4754</issn><issn>1615-7109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>EIF</sourceid><recordid>eNp1kktv1DAQxyMEoqXwAbggS1zKIcV2_Eg4VFqVFIqKWHW358jJTnanJPFie1fafrp-NLyklJc4WPZofvOfhydJXjJ6wpjWbxmnmdBScM4Yz3WhHiWHTDGZakaLx_Ed_ekeOEieeX9DKWVMiqfJQaY4E1mmD5O764Ad3pqAdiC2JWEFZOqtQ-PRk3KNC-jRdna5I7PGAQw4LMnc2o4cT8vZ_M07MiFX6L-SWXBRpMVmlPphQoxqrSOlcd2OXEELzplun2ZMEbAhExdWDkNMNo02DMGTYMlnHLDHWyAXzsEWnMe6A1I663EL5JPFIZD3pjdLeJ48aU3n4cX9fZRcn5fzs4_p5ZcPF2eTy7QRSoWU81oIIWUueFGLBrha5Dmvc90YWSjBclZoQw1VWigOEnTOZb4ApanUtTQsO0pOR931pu5h0cRKYy_V2mFv3K6yBqs_PQOuqqXdVoXmRTxR4PhewNlvG_Ch6tE30HVmALvxFY-MyDMm84i-_gu9sRs3xPYiJXT8bqpkpNhINXEs3kH7UAyj1X4_qn_2I8a8-r2Lh4ifCxGBkxHwcba_0v5f8TsSB8UG</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Chang, Jasmine</creator><creator>Litvinov, Ivan V.</creator><creator>Ly, Christina</creator><creator>Netchiporouk, Elena</creator><creator>Tsoukas, Alexander</creator><creator>Thuraisingam, Thusanth</creator><creator>Starr, Michael</creator><creator>Powell, Mathieu</creator><creator>Christodoulou, George</creator><creator>Shamout, Yassein</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0562-4675</orcidid><orcidid>https://orcid.org/0000-0001-8414-6354</orcidid><orcidid>https://orcid.org/0000-0001-5063-8991</orcidid><orcidid>https://orcid.org/0000-0002-6692-7787</orcidid></search><sort><creationdate>20221101</creationdate><title>Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage</title><author>Chang, Jasmine ; Litvinov, Ivan V. ; Ly, Christina ; Netchiporouk, Elena ; Tsoukas, Alexander ; Thuraisingam, Thusanth ; Starr, Michael ; Powell, Mathieu ; Christodoulou, George ; Shamout, Yassein</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-22b444558429b4ce26d882b87ca596418197a0a067462e5e78258de67057b5a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Arthritis, Psoriatic - diagnosis</topic><topic>Arthritis, Psoriatic - drug therapy</topic><topic>Arthritis, Psoriatic - epidemiology</topic><topic>Humans</topic><topic>Medical screening</topic><topic>Original</topic><topic>Prospective Studies</topic><topic>Psoriasis</topic><topic>Psoriasis - complications</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriasis - epidemiology</topic><topic>Psoriatic arthritis</topic><topic>Referral and Consultation</topic><topic>Rheumatology</topic><topic>Risk Assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Jasmine</creatorcontrib><creatorcontrib>Litvinov, Ivan V.</creatorcontrib><creatorcontrib>Ly, Christina</creatorcontrib><creatorcontrib>Netchiporouk, Elena</creatorcontrib><creatorcontrib>Tsoukas, Alexander</creatorcontrib><creatorcontrib>Thuraisingam, Thusanth</creatorcontrib><creatorcontrib>Starr, Michael</creatorcontrib><creatorcontrib>Powell, Mathieu</creatorcontrib><creatorcontrib>Christodoulou, George</creatorcontrib><creatorcontrib>Shamout, Yassein</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cutaneous medicine and surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Jasmine</au><au>Litvinov, Ivan V.</au><au>Ly, Christina</au><au>Netchiporouk, Elena</au><au>Tsoukas, Alexander</au><au>Thuraisingam, Thusanth</au><au>Starr, Michael</au><au>Powell, Mathieu</au><au>Christodoulou, George</au><au>Shamout, Yassein</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage</atitle><jtitle>Journal of cutaneous medicine and surgery</jtitle><addtitle>J Cutan Med Surg</addtitle><date>2022-11-01</date><risdate>2022</risdate><volume>26</volume><issue>6</issue><spage>600</spage><epage>603</epage><pages>600-603</pages><issn>1203-4754</issn><eissn>1615-7109</eissn><abstract>Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain undiagnosed. Early detection and referral to a rheumatologist are crucial to optimize care and minimize irreversible erosive joint damage. To improve the rheumatology referral process, the authors propose a risk stratification tool to identify and triage patients with possible psoriatic arthritis. With the aim of ultimately assisting in early treatment initiation, this risk stratification algorithm can be used in both dermatology and primary care clinics. It is based on the Psoriasis Epidemiology Screening Tool (PEST) combined with the ClASsification criteria for Psoriatic Arthritis (CASPAR). This article intends to provide a rationale for further prospective studies whose objective would be to validate this screening algorithm.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>36214337</pmid><doi>10.1177/12034754221128796</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-0562-4675</orcidid><orcidid>https://orcid.org/0000-0001-8414-6354</orcidid><orcidid>https://orcid.org/0000-0001-5063-8991</orcidid><orcidid>https://orcid.org/0000-0002-6692-7787</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1203-4754 |
ispartof | Journal of cutaneous medicine and surgery, 2022-11, Vol.26 (6), p.600-603 |
issn | 1203-4754 1615-7109 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9729972 |
source | MEDLINE; SAGE Complete A-Z List |
subjects | Arthritis, Psoriatic - diagnosis Arthritis, Psoriatic - drug therapy Arthritis, Psoriatic - epidemiology Humans Medical screening Original Prospective Studies Psoriasis Psoriasis - complications Psoriasis - drug therapy Psoriasis - epidemiology Psoriatic arthritis Referral and Consultation Rheumatology Risk Assessment |
title | Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A21%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utilization%20of%20the%20Psoriasis%20Epidemiology%20Screening%20Tool%20(PEST):%20A%20Risk%20Stratification%20Strategy%20for%20Early%20Referral%20of%20Psoriatic%20Arthritis%20Patients%20to%20Minimize%20Irreversible%20Erosive%20Joint%20Damage&rft.jtitle=Journal%20of%20cutaneous%20medicine%20and%20surgery&rft.au=Chang,%20Jasmine&rft.date=2022-11-01&rft.volume=26&rft.issue=6&rft.spage=600&rft.epage=603&rft.pages=600-603&rft.issn=1203-4754&rft.eissn=1615-7109&rft_id=info:doi/10.1177/12034754221128796&rft_dat=%3Cproquest_pubme%3E2747221065%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2747221065&rft_id=info:pmid/36214337&rft_sage_id=10.1177_12034754221128796&rfr_iscdi=true |